Related Experiment Video
Updated: Jan 10, 2026

09:02
Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform
Published on: November 10, 2016
10.7K
Europium Complex-Loaded Albumin Nanoparticles as Probes for Time-Resolved Luminescent Immunoassay
Zarina Galaeva1,2, Maria Bochkova1,2, Mikhail Rayev1,2
1Institute of Ecology and Genetics of Microorganisms, Ural Branch of RAS, Perm 614081, Russia.
Biosensors
|November 26, 2025
Summary
Albumin nanoparticles loaded with europium complexes offer a novel approach for immunoassay development. This method simplifies detection and enhances signal for human IgG quantification, though reproducibility needs further improvement.
Area of Science:
- Biomaterials Science
- Analytical Chemistry
- Immunotechnology
Background:
- Immunoassays are crucial for disease diagnosis and monitoring.
- Existing methods like DELFIA assays often require signal enhancement steps.
- Development of novel labeling strategies for enhanced immunoassay performance is ongoing.
Purpose of the Study:
- To develop and validate albumin nanoparticles loaded with luminescent europium complexes for immunoassay applications.
- To evaluate the performance of these nanoparticles as labels in a time-resolved immunoassay for human IgG detection.
- To compare the developed assay with commercial immunoassay kits.
Main Methods:
- Albumin nanoparticles synthesized via desolvation, loaded with europium complexes, and functionalized with streptavidin.
- Application of nanoparticles as labels in a sandwich time-resolved solid-phase immunoassay.
- Detection of human IgG in serum samples using time-resolved fluorescence detection.
Main Results:
- Nanoparticles exhibited uniform morphology, hydrodynamic diameter of 263 nm, and strong luminescence at 615 nm.
- The immunoassay showed a tenfold increase in signal intensity and a two-order reduction in background compared to conventional methods.
- The assay demonstrated high sensitivity, detecting human IgG at dilutions up to 1:100,000 with minimal cross-reactivity.
- Strong concordance with commercial immunoassays was observed, with suboptimal intra-assay reproducibility as a limitation.
Conclusions:
- Albumin-europium nanoparticles represent a promising, label-free approach for sensitive immunoassay development.
- The intrinsic luminescence of the nanoparticles simplifies assay procedures by eliminating signal enhancement steps.
- Further optimization is needed to address assay reproducibility challenges for widespread clinical application.

